SynthesisFood and environmental virology2025
Prevalence of Human Bocavirus in Sewage, Surface Waters, and Other Environmental Milieux: A Meta-regression Modelling.
Synthesis in Food and environmental virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tracking the occurrence and fate of human bocavirus 2 in municipal wastewater from a small city.Molecular biology reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Environmental matrices (EMs) are important reservoirs for the human bocavirus (HBoV). This study aimed to determine HBoV prevalence in EMs and model its association with SDG6.3.1 (wastewater production (WWp), collection (WWc), treatment (WWt), and reuse (WWr)). HBoV data-mined from EMs were fitted to a random-intercept-logistic regression/1000-bootstrapped-based meta-regressions. HBoV global prevalence in EMs was 42.19% (95%CI: 28.07-57.72), and varied non-statistically across continents (North America (66.59%), Africa (42.32%), Europe (41.95%), Asia (39.96%), South America (20.55%)), economies (high-income (45.04%) > upper-middle-income (42.56%) > lower-middle-income (41.35%)), WHO regions (Western Europe (41.95%) > Middle East & North Africa (41.35%) > East Asia & Pacific (39.96%) > North America (66.59%) > Latin America & Caribbean (20.55%)) but significantly across dwelling settings (urban: 52.02% versus rural: 20.29%) and sample types (raw sewage (RS, 73.16%) > treated sewage (TS, 43.47%) > sewage sludge (SS, 19.87%) > sediment (13.24%) > surface waters (18.55%)). HBoV subtypes circulating in EMs varied among sample types (HBoV1 in TS (40.74%) > RS (22.45%) > surface water (9.09%); HBoV2 in RS (75.42%) > TS (54.82%) > surface water (18.24%); HBoV3 in RS (64.74%) > TS (58.95%) > surface water (6.48%) > SS (3.49%)). HBoV prevalence in EMs had direct relationship (p ≤ 0.05) with SDG6.3.1 variables (WWp: F
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.